发明名称 PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF DISEASE TRANSMITTED BY TUMOR NECROSIS FACTOR
摘要 PROBLEM TO BE SOLVED: To obtain the subject composition for treatment or prevention of diseases transmitted by tumor necrosis factor(TNF), in particular TNF- transmitted septic shock, arthritis and adult respiratory distress syndromes by including a recombinant TNF inhibitor having a specific amino acid sequence. SOLUTION: This composition contains a recombinant TNF inhibitor having an amino acid sequence shown by the formula and composed of a 30 kDa inhibitor containing a nonnaturally occurring cysteine residue in the 105th amino acid residue. It is preferable to administer the TNF inhibitor at a dose of 150 mg/kg-body weight/24 h at intervals of 3 h. It is also preferable to continue the administration for at least 24 h. The TNF inhibitor can be bound to a repeated polymer component. Polyethylene glycol is the preferable polymer component. It is preferable to administer the composition parenterally by infection.
申请公布号 JPH11199505(A) 申请公布日期 1999.07.27
申请号 JP19980295988 申请日期 1998.09.10
申请人 SYNERGEN INC 发明人 CARMICHAEL DAVID F;SMITH CHRISTOPHER G;ROBERT C THOMPSON;RUSSELL DEBORAH;KOHNO TADAHIKO
分类号 A61K38/00;A61K31/00;A61K38/02;A61K38/16;A61K47/34;A61P1/00;A61P9/00;A61P11/00;A61P11/16;A61P19/00;A61P19/02;A61P29/00;A61P31/00;A61P31/04;A61P37/00;A61P43/00;C07K14/525;C07K14/715;C12P21/00;C12P21/02 主分类号 A61K38/00
代理机构 代理人
主权项
地址